Charles River Laboratories International (CRL) Form 3 CHARLES RIVER LABORATORIES INTERNATIONAL / Birgit Girshick ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Girshick Birgit

(Last) (First) (Middle)

251 BALLARDVALE STREET

(Street)

WILMINGTON MA 01887

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/13/2018

3. Issuer Name and Ticker or Trading Symbol
CHARLES RIVER LABORATORIES INTERNATIONAL INC [ CRL ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Corporate Executive VP

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	23,182(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	02/28/2015(2)	02/28/2021	Common Stock	913	59.41	D
Stock Options (Right to Buy)	02/27/2016(3)	02/27/2020	Common Stock	2,466	76.67	D
Stock Options (Right to Buy)	02/26/2017(4)	02/26/2021	Common Stock	5,025	73.7	D
Stock Options (Right to Buy)	02/24/2018(5)	02/24/2022	Common Stock	13,969	88.05	D

Explanation of Responses:

1. Consists of: (a) 18,466 shares of common stock; (b) 233 shares of restricted stock which will vest on 2/28/2018; (c) 4,483 unvested restricted stock units (RSUs) which vest as follows: 724 on 2/24/2018, 342 on 2/26/2018, 279 on 2/27/2018, 725 on 2/24/2019, 341 on 2/26/2019, 280 on 2/27/2019, 725 on 2/24/2020, 342 on 2/26/2020, and 725 on 2/24/2021. Each RSU represents a contingent right to receive one share of common stock.

2. Stock options will vest as follows: 913 on 2/28/2018.

3. Stock Options will vest as follows: 1,233 on 2/27/2018 and 1,233 on 2/27/2019.

4. Stock Options will vest as follows: 1,675 on 2/26/2018, 1,675 on 2/26/2019 and 1,675 on 2/26/2020.

5. Stock Options will vest as follows: 3,492 on 2/24/2018, 3,492 on 2/24/2019, 3,492 on 2/24/2020 and 3,493 on 2/24/2021.

	/s/ Birgit Girshick	02/20/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.